cumberlandpharma.com (CPIX) Company Sales Revenue

cumberlandpharma.com - graphic logo of issuer CPIX

Cumberland Pharmaceuticals (CPIX) develops innovative hospital products, including injectable acetaminophen and antidotes. After assessing the company's commercial revenue on GURU.Markets, we find that management's experience in niche sales influences the dynamics, where the value of 0.03 shows the current magnitude. In its maturity stage, the business relies on a diversified portfolio, planning sales growth by 2026.

Company Sales: Cumberland Pharma (CPIX) for 07/04/2022 - 11/17/2026

Comprehensive metric breakdowns and analytics for Cumberland Pharma (CPIX)

- market price and analyst price targets:
Summary company analysis:CPIX (cumberlandpharma.com)
Signature product of Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals (CPIX) monetizes the exclusivity of niche hospital drugs through strategic price indexing. The algorithm aggregates actual cash receipts from clients, filtering out market noise and price volatility. This metric objectifies the real cash flow, allowing for an assessment of the business's fundamental stability independent of emotional trader spikes. Analyzing the company's aggregated sales helps investors identify trend reversals in a timely manner and optimize their entry point.

Analysis of competing companies

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Ligand Pharma - Company Revenue|AMRX - Company Revenue|Company Total Revenue perrigo.com|ALVO (Alvotech SA) - Company Sales|Company Total Sales Volume Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Revenue and Sales Volume|ANIP: Company Sales Revenue|Company Revenue Afrezza (MNKD)|Revenue and Sales Volume amphastar.com (AMPH)|Revenue and Sales Volume PCRX (pacira.com)|Company Sales Revenue SPRY|Theravance Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Aquestive Therapeutics AQST|SCPH: Revenue and Sales Volume|Company Sales Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Revenue and Sales Volume|SXTC (China SXT Pharmaceuticals, Inc.) - Company Total Sales|Company Revenue eupraxiapharma.com (EPRX)|Company Total Sales BHST|Company Revenue eXoZymes EXOZ|Company Sales Revenue ORMP|ENTX - Company Revenue|HYFT: Company Revenue|ABVC BioPharma, Inc (ABVC) - Company Revenue|Quantum BioPharma Limited - Company Sales Revenue|FGEN (FibroGen Corp) - Revenue and Sales Volume|Revenue and Sales Volume Telomir Pharmaceuticals|Revenue and Sales Volume RANI|SNYR (Synergy CHC Corp.) - Company Sales Revenue|Revenue and Sales Volume RLYB (Rallybio Corp)|LEXX: Company Sales Volume|PULM - Company Revenue|PTHL: Company Revenue|APM (aptorumgroup.com) - Company Sales|Lyra Therapeutics - Company Sales Revenue|Company Revenue Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Company Gross Revenue|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP